Amolyt Pharma to Present Full Phase 2a Data on AZP-3601 at Upcoming Conferences
Data from cohort 2 and full Phase 2a clinical trial to be presented at the 38th Congress of the French Society of Endocrinology and 2022 International HypoPARAthyroidism ConferenceLYON, France and CAMBRIDGE